Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreatic D cell | 3 studies | 38% ± 26% | |
pancreatic A cell | 3 studies | 43% ± 28% | |
type B pancreatic cell | 3 studies | 34% ± 11% |
Insufficient scRNA-seq data for expression of CNIH2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 6106.50 | 2575 / 2642 | 100% | 59.76 | 702 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.83 | 1 / 1 |
adrenal gland | 12% | 109.57 | 31 / 258 | 70% | 44.54 | 162 / 230 |
breast | 0% | 0 | 0 / 459 | 70% | 7.83 | 778 / 1118 |
uterus | 0% | 0 | 0 / 170 | 69% | 9.06 | 319 / 459 |
tonsil | 0% | 0 | 0 / 0 | 64% | 5.96 | 29 / 45 |
ovary | 0% | 0 | 0 / 180 | 64% | 6.68 | 276 / 430 |
skin | 1% | 2.64 | 11 / 1809 | 53% | 4.40 | 251 / 472 |
pancreas | 6% | 30.25 | 19 / 328 | 47% | 10.03 | 84 / 178 |
esophagus | 0% | 0 | 0 / 1445 | 43% | 4.96 | 79 / 183 |
eye | 0% | 0 | 0 / 0 | 43% | 2.08 | 34 / 80 |
lung | 1% | 5.42 | 7 / 578 | 29% | 2.45 | 336 / 1155 |
bladder | 0% | 0 | 0 / 21 | 24% | 3.03 | 122 / 504 |
thymus | 0% | 2.19 | 2 / 653 | 11% | 0.85 | 67 / 605 |
prostate | 0% | 0 | 0 / 245 | 8% | 0.39 | 39 / 502 |
stomach | 1% | 3.21 | 2 / 359 | 7% | 1.28 | 20 / 286 |
intestine | 0% | 0.94 | 2 / 966 | 6% | 0.65 | 29 / 527 |
liver | 0% | 0 | 0 / 226 | 4% | 0.28 | 17 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.12 | 1 / 29 |
kidney | 0% | 0 | 0 / 89 | 2% | 0.11 | 22 / 901 |
peripheral blood | 0% | 1.00 | 2 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.39 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.29 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_2000311 | Biological process | regulation of AMPA receptor activity |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0045202 | Cellular component | synapse |
GO_0032281 | Cellular component | AMPA glutamate receptor complex |
GO_0043197 | Cellular component | dendritic spine |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043198 | Cellular component | dendritic shaft |
GO_0030425 | Cellular component | dendrite |
GO_0005515 | Molecular function | protein binding |
Gene name | CNIH2 |
Protein name | Cornichon family AMPA receptor auxiliary protein 2 Protein cornichon homolog 2 (Cornichon family AMPA receptor auxiliary protein 2) Protein cornichon homolog 2 (CNIH-2) (Cornichon family AMPA receptor auxiliary protein 2) (Cornichon-like protein) |
Synonyms | CNIL |
Description | FUNCTION: Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs). Promotes their targeting to the cell membrane and synapses and modulates their gating properties by regulating their rates of activation, deactivation and desensitization. Blocks CACNG8-mediated resensitization of AMPA receptors. . |
Accessions | E9PJQ8 E9PIT8 ENST00000528063.5 ENST00000534826.5 ENST00000311445.7 Q6PI25 ENST00000528852.5 E9PS15 |